Cargando…

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease

Alanine aminotransferase (ALT) is the most commonly used marker of liver injury, but normal ALT levels are seen in a proportion of chronic hepatitis B virus (HBV)-infected patients with severe liver injury. Golgi protein 73 (GP73) is a promising alternative marker of liver injury. This study assesse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zhengju, Liu, Liguan, Pan, Xingnan, Wei, Kaipeng, Wei, Meijuan, Liu, Lifei, Yang, Huanwen, Liu, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554005/ https://www.ncbi.nlm.nih.gov/pubmed/25816035 http://dx.doi.org/10.1097/MD.0000000000000659

Ejemplares similares

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT
por: Wei, Meijuan, et al.
Publicado: (2019)

Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B
por: XU, ZHENGJU, et al.
Publicado: (2015)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections
por: Wei, Hongshan, et al.
Publicado: (2013)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021)

GP73, a novel Golgi-localized protein upregulated by viral infection
por: Kladney, Raleigh D., et al.
Publicado: (2000)

Application of serum Golgi protein-73 in the management of chronic liver disease
por: Yao, Ming-Jie, et al.
Publicado: (2021)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences
por: Hu, Longbo, et al.
Publicado: (2011)

Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer
por: Xu, Zheng-Ju, et al.
Publicado: (2022)

Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection
por: Zhang, Xiaoman, et al.
Publicado: (2019)

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
por: Sai, Wenli, et al.
Publicado: (2015)

Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States
por: Vutien, Philip, et al.
Publicado: (2016)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Golgi protein 73 and its diagnostic value in liver diseases
por: Xia, Yanyan, et al.
Publicado: (2018)

Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis
por: Zhang, Xu, et al.
Publicado: (2023)

Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
por: Ke, Meng-yun, et al.
Publicado: (2019)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)
por: Bao, Yong xing, et al.
Publicado: (2013)

Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis
por: Yao, Mingjie, et al.
Publicado: (2022)

Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma
por: Hu, Xinyang, et al.
Publicado: (2023)

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013)

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
por: Wang, Leijie, et al.
Publicado: (2020)

Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer
por: Yuan, Jun-Jian, et al.
Publicado: (2022)

c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment
por: Liu, Yiming, et al.
Publicado: (2019)

Golgi protein 73, hepatocellular carcinoma and other types of cancers
por: Wang, Yanan, et al.
Publicado: (2020)

Clinical significance of golgi protein‐73 as a diagnostic marker for Egyptian patients with colorectal cancer: Preliminary study
por: Abdelhady, Shaymaa Abdelraheem, et al.
Publicado: (2021)

Screening and Identification of ssDNA Aptamer for Human GP73
por: Du, Jingchun, et al.
Publicado: (2015)

Expression and correlation of CD44 and GP73 in cerebroma tissues
por: Yuan, Yuan, et al.
Publicado: (2018)

A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients
por: Zhang, Jian, et al.
Publicado: (2019)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
por: Yang, Danli, et al.
Publicado: (2021)

GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
por: Yang, Xiaoli, et al.
Publicado: (2017)

Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance
por: Donizy, Piotr, et al.
Publicado: (2016)

Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis
por: Zhu, ShaoMing, et al.
Publicado: (2017)

Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis
por: YANG, JING, et al.
Publicado: (2015)

Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
por: Dai, Meiyu, et al.
Publicado: (2015)

GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness
por: Jiang, Kai, et al.
Publicado: (2016)

Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis
por: Zhang, Xueyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_smftgnde7o0h5rvor8vk26govb